🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Oral selexipag is commercially available in several countries for the treat...
Status
Terminated
Location
St. Vincent Medical Group, Inc.
Start Date
2021-02-26
Trial ID
NCT03942211
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Clinical Research Center of Alabama
Start Date
2017-05-30
Trial ID
NCT03131648
Treatments Being Tested
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded,...
Status
Recruiting
Location
University of California, San Diego: Dermatology Clinical Trials Unit
Start Date
2025-05-22
Trial ID
NCT06504160
Major depressive disorder (MDD) is a common, recurrent, and frequent chroni...
Status
Unknown
Location
Ludwig-Maximilian University
Start Date
2021-06-22
Trial ID
NCT04953208
Treatments Being Tested
This is a two-part, multicenter, randomized, double-blind study to evaluate...
Status
Terminated
Location
Cara Therapeutics Study Site
Start Date
2022-08-16
Trial ID
NCT05387707
Treatments Being Tested
This extension study (CZPL389A2203E1) was designed as a 2-year (100 weeks) ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-04-04
Trial ID
NCT03948334
Treatments Being Tested
This phase 2b study is designed to evaluate the safety and efficacy of teze...
Status
Terminated
Location
First OC Dermatology
Start Date
2019-03-15
Trial ID
NCT03809663
Treatments Being Tested
To investigate the safety and tolerability of repeated subcutaneous (s.c.) ...
Status
Terminated
Location
First OC Dermatology
Start Date
2019-03-25
Trial ID
NCT03864627
This randomized, double-blind, placebo-controlled study will evaluate the s...
Status
Completed
Location
Dermatology Research Associate
Start Date
2015-05
Trial ID
NCT02340234
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Completed
Location
Investigate MD
Start Date
2020-02-03
Trial ID
NCT04250337
Treatments Being Tested